List of SBIR/STTR awards granted to Symberix
SymberixName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Symberix in September, 2019 for $987,570.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA233157-02 | Phase II | 987,570 | September 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Symberix in August, 2018 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA233157-01 | Phase I | 300,000 | August 20, 2018 | |||||||
A SBIR Phase I contract was awarded to Symberix in April, 2018 for $238,047.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK117815-01A1 | Phase I | 238,047 | April 1, 2018 | |||||||
A SBIR Phase II contract was awarded to Symberix in July, 2020 for $884,165.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44GM128477-02 | Phase II | 884,165 | July 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Symberix in May, 2019 for $231,302.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK121564-01 | Phase I | 231,302 | May 1, 2019 | |||||||
A SBIR Phase II contract was awarded to Symberix in May, 2020 for $625,834.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44TR002691-02 | Phase II | 625,834 | May 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Symberix in May, 2019 for $224,953.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44TR002691-01 | Phase I | 224,953 | May 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Symberix in April, 2018 for $220,944.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM128477-01 | Phase I | 220,944 | April 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Symberix in June, 2022 for $304,553.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK131674-01A1 | Phase I | 304,553 | June 10, 2022 | |||||||
A SBIR Phase I contract was awarded to Symberix in September, 2015 for $215,706.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK108379-01 | Phase I | 215,706 | September 17, 2015 | |||||||
A SBIR Phase I contract was awarded to Symberix for $268,641.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201600056C-0-0-0 | Phase I | 268,641 | ||||||||
A SBIR Phase I contract was awarded to Symberix for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA180270-01A1 | Phase I | 225,000 |
